Here are five things to know.
- The medical device tax entails a 2.3 percent excise tax on the sale of certain medical devices, payable by the manufacturer or importer of the device. The tax was imposed in 2013 as a funding mechanism for the ACA.
- Devicemakers have long opposed the tax, arguing it hurts innovation and unfairly burdens smaller device manufacturers.
- In 2015, Congress temporarily suspended the tax on the sale of nonretail medical devices like pacemakers, heart valves and artificial hips.
- The Senate bill would permanently repeal the tax before it takes effect again in 2018.
- The American Healthcare Act, passed in the House last month, also called for a repeal of the tax.
More articles on supply chain:
Drug manufacturer, distributor shut down for producing unapproved medications
Sanofi CEO on SCOTUS’ biologics ruling: 3 takeaways
Whole Foods acquisition could move Amazon closer to pharmacies
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.